ELAN Elanco Animal Health Inc

  1. Stocks
  2. Healthcare
  3. NYSE: ELAN

Price (delayed)

$11.78

Market cap

$5.81B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.32

Enterprise value

$11.35B

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, ...

Highlights
The debt is down by 2.5% since the previous quarter
The quick ratio has grown by 29% YoY but it has contracted by 4% from the previous quarter
ELAN's equity is down by 17% from the previous quarter and by 9% YoY
Elanco Animal Health's revenue has decreased by 3.9% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Peers: OGN

Key stats

What are the main financial stats of ELAN
Market
Shares outstanding
492.8M
Market cap
$5.81B
Enterprise value
$11.35B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.95
Price to sales (P/S)
1.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.6
Earnings
Revenue
$4.36B
EBIT
-$879M
EBITDA
-$188M
Free cash flow
-$49M
Per share
EPS
-$2.32
Free cash flow per share
-$0.1
Book value per share
$12.45
Revenue per share
$8.86
TBVPS
$10.08
Balance sheet
Total assets
$14.34B
Total liabilities
$8.21B
Debt
$5.91B
Equity
$6.13B
Working capital
$2.3B
Liquidity
Debt to equity
0.96
Current ratio
2.82
Quick ratio
1.19
Net debt/EBITDA
-29.47
Margins
EBITDA margin
-4.3%
Gross margin
57.3%
Net margin
-26.2%
Operating margin
-20.1%
Efficiency
Return on assets
-7.5%
Return on equity
-16.2%
Return on invested capital
-9.7%
Return on capital employed
-6.7%
Return on sales
-20.1%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ELAN stock price

How has the Elanco Animal Health stock price performed over time
Intraday
-2%
1 week
-1.26%
1 month
33.71%
1 year
-8.47%
YTD
-3.6%
QTD
4.8%

Financial performance

How have Elanco Animal Health's revenue and profit performed over time
Revenue
$4.36B
Gross profit
$2.5B
Operating income
-$879M
Net income
-$1.15B
Gross margin
57.3%
Net margin
-26.2%
Elanco Animal Health's revenue has decreased by 3.9% YoY
The gross profit has contracted by 2.5% YoY

Growth

What is Elanco Animal Health's growth rate over time

Valuation

What is Elanco Animal Health stock price valuation
ELAN P/E details
P/E
N/A
P/B
0.95
P/S
1.33
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.6
The price to book (P/B) is 37% lower than the 5-year quarterly average of 1.5 but 36% higher than the last 4 quarters average of 0.7
ELAN's equity is down by 17% from the previous quarter and by 9% YoY
ELAN's P/S is 54% below its 5-year quarterly average of 2.9 but 11% above its last 4 quarters average of 1.2
Elanco Animal Health's revenue has decreased by 3.9% YoY

Efficiency

How efficient is Elanco Animal Health business performance

Dividends

What is ELAN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ELAN.

Financial health

How did Elanco Animal Health financials performed over time
Elanco Animal Health's total assets is 75% higher than its total liabilities
Elanco Animal Health's current ratio has increased by 44% YoY
The quick ratio has grown by 29% YoY but it has contracted by 4% from the previous quarter
The debt is 3.7% smaller than the equity
ELAN's equity is down by 17% from the previous quarter and by 9% YoY
The debt to equity has increased by 17% since the previous quarter and by 10% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.